Clinical Trial Update: Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study） [Phase 3]

View source ↗

Summary

Phase 3 AOBA study evaluating KK8398 in Achondroplasia is currently recruiting; the trial aims to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• KK8398

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Achondroplasia | Phase 3 | Status: RECRUITING